Welcome to our dedicated page for Stemsation International news (Ticker: STSN), a resource for investors and traders seeking the latest updates and insights on Stemsation International stock.
Stemsation International Inc (STSN) delivers natural wellness solutions through scientifically formulated products and an innovative direct-to-consumer model. This page serves as your definitive source for official company news and announcements.
Access timely updates on product developments, financial results, and strategic initiatives including acquisitions and rebranding efforts. Investors will find earnings reports and corporate governance updates, while consumers can track new product launches and scientific research milestones.
Our curated news collection ensures you stay informed about STSN's unique network marketing approach and advancements in stem cell support formulations. Bookmark this page for direct access to press releases covering regulatory updates, partnership announcements, and market expansion strategies.
StemSation International (OTC: STSN) has announced filing to change its name to Smart TrendS Network to align with its current business strategy. The company, which has moved away from its previous network marketing model in mid-2022, now focuses on retail distribution of various trending products. The company has licensed technology for flavored canned oxygen products and recently acquired Gorilla Marketing Group (GMG), which distributes high-end vape products under the AlienHouse brand, including disposable vape cartridges and THC-P hemp derivatives. The rebranding reflects the company's strategy to identify, acquire, and market various trending products through their retail distribution platform.
StemSation International announced the completion of its acquisition of Gorilla Marketing Group (GMG), a private marketing company known for its high-end AlienHouse vape product line. This strategic move aims to position StemSation for significant growth in the THC-P vape and lifestyle product markets.
With GMG's established brand and innovative marketing, StemSation plans to expand distribution, improve efficiencies, and support new product launches in high-potential retail spaces. GMG’s leadership will join StemSation’s Board of Directors, and GMG shareholders will acquire approximately 35% ownership in StemSation’s common shares.
Leveraging GMG's creative branding and the growing popularity of THC-P products, StemSation anticipates substantial growth aligned with record-breaking sales trends in convenience stores and the broader consumer goods sector.
StemSation previously announced a Letter of Intent outlining the terms and milestone steps of the acquisition. GMG's product line includes disposable vape cartridges in a range of flavors and THC-P hemp derivatives, along with branded apparel and marketing materials.
StemSation International (OTC: STSN) has executed a Letter of Intent to acquire 100% of Gorilla Marketing Group, (GMG), a private marketing company. GMG owns and distributes high-end vape products under the AlienHouse brand, including disposable vape cartridges and THC-P hemp derivatives. The acquisition aligns with StemSation's focus on the consumer goods space, particularly in convenience store impulse buy areas.
Key points:
- GMG management will join StemSation upon completion
- Definitive agreements and audited financials are required
- Acquisition expected to be completed by year-end
- StemSation aims to seek additional companies for growth
- Convenience stores saw record in-store sales of $327.6 billion in 2023
StemSation International (OTC: STSN), a South-Florida based company, has provided corporate updates on their expanded business model. The company, which has licensed technology for flavored, canned oxygen products, is exploring new business initiatives. CEO Benjamin Silber stated that while they initially targeted green energy companies for acquisition, they are now focusing on opportunities in the consumer goods sector, particularly 'impulse buy' products for convenience store cash registers.
This shift aligns with recent data from the National Association of Convenience Stores (NACS), which reported record sales of $859.8 billion in 2023, including $327.6 billion from in-store sales. StemSation aims to leverage the sales advantage of register space, where customers have already committed to making a purchase. The company expects to provide additional updates on their business plan shortly.
StemSation International (OTC PINK:STSN) has received registration for four trademarks from the United States Patent & Trademark Office through its subsidiary, StemSation IP Holding LLC. The trademarks include StemSation, StemRCM, ProStem PSP, and StemFlex. President Ray Carter emphasized the significance of this achievement for building a strong intellectual property portfolio. The company is expanding globally, with plans to enter Latin American markets by the end of 2021. StemSation develops all-natural wellness products focused on stem cells and endocannabinoids, marketed through Independent Wellness Advocates.
StemSation International, Inc. (OTC PINK:STSN) reported a 24% increase in revenues for Q2 2020, totaling $65,405 compared to $52,675 in Q1 2020. The company also reduced overhead costs by 18% as start-up expenses subsided. President & CEO Ray Carter expressed optimism about continued growth and marketing expansion despite challenges posed by COVID-19. StemSation is focused on natural health products that support stem cell and endocannabinoid systems and aims to enter Latin American markets by the end of 2020.
StemSation International (OTC: STSN) has partnered with First Class Alliance (FCA), a leading digital marketing agency, to enhance its online presence amidst a rapidly growing market for CBD products. This collaboration aims to boost brand awareness and improve consumer engagement. The global CBD market is projected to rise from $9.2 billion in 2020 to over $23.6 billion by 2025. Additionally, bone and joint health concerns are increasing, particularly among aging populations. StemSation focuses on developing natural wellness products that target stem cell and endocannabinoid systems.
